-
Find a Clinical Trial
-
Get Connected
-
Scientific Report
-
Get Involved
-
About MRA
In advance of Melanoma Awareness Month, the Melanoma Research Alliance (MRA), the largest non-profit funder of melanoma research, today announced funding for 33 innovative research awards totaling $8.26 million.
We know that the billions of bacteria that live in our bodies can impact the way we respond to immunotherapy, but can we harness this help more patients respond these life-saving drugs?
After being diagnosed with Stage 3 melanoma, Chris Eyrich is committed to raising awareness about melanoma. He works to raise awareness of the unique occupational hazards faced by people who work primarily outdoors, such as police officers and other public servants.
We know that the billions of bacteria that live in our bodies can impact the way we respond to immunotherapy, but can we harness this help more patients respond these life-saving drugs?
For Brendan, his journey with melanoma began on Mother's Day Weekend in 2009 when he noticed a weird, ugly looking mole. He channeled this experience and cofounded the annual Leveraged Finance Fights Melanoma (LFFM) benefit that brings more than 1,000 members of the leveraged finance and private equity community together each year. In eight years, LFFM has raised over $10 million for melanoma research.
